BIOCHEMICAL DETERMINANTS OF ADRIAMYCIN TOXICITY IN MOUSE-LIVER, HEART AND INTESTINE

被引:74
作者
ODOM, AL [1 ]
HATWIG, CA [1 ]
STANLEY, JS [1 ]
BENSON, AM [1 ]
机构
[1] UNIV ARKANSAS MED SCI HOSP, DEPT BIOCHEM & MOLEC BIOL, SLOT 516, 4301 W MARKHAM ST, LITTLE ROCK, AR 72205 USA
关键词
D O I
10.1016/0006-2952(92)90250-M
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Biochemical characteristics relevant to the differential susceptibilities of liver, heart, and intestine to acute Adriamycin(R) toxicity were examined in female CD-1 mice with and without intravenous Adriamycin (dose range 23-30 mg/kg). The liver which, unlike heart and intestine, is relatively resistant to Adriamycin toxicity, had high levels of glutathione and glutathione peroxidase, and exhibited a sharp decline in non-protein thiol concentrations within 1-3 hr with rebound by 6 hr after Adriamycin. Covalent binding to Adriamycin or its metabolites could not account quantitatively for the loss of non-protein thiols, implicating an oxidative mechanism. No lipid peroxidation was observed in the liver, apparently due to effective utilization of antioxidant defenses. Adriamycin caused significant increases in cardiac lipid peroxides, indicative of oxidative tissue damage, which would be expected to exacerbate cardiotoxicity. However, non-protein thiol concentrations did not decrease in heart or in intestine in response to Adriamycin. Both heart and intestine had extremely low levels of glutathione peroxidase activity, which may limit glutathione utilization for protection against oxidative toxicity. The activity of DT diaphorase, which may have an activating role in Adriamycin metabolism, was high in heart and intestine and was induced 4-fold in liver in response to Adriamycin.
引用
收藏
页码:831 / 836
页数:6
相关论文
共 39 条
[1]  
BENSON AM, 1979, CANCER RES, V39, P2971
[2]  
BENSON AM, 1986, J NATL CANCER I, V76, P467
[3]   INCREASE OF NAD(P)H-QUINONE REDUCTASE BY DIETARY ANTIOXIDANTS - POSSIBLE ROLE IN PROTECTION AGAINST CARCINOGENESIS AND TOXICITY [J].
BENSON, AM ;
HUNKELER, MJ ;
TALALAY, P .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1980, 77 (09) :5216-5220
[4]  
BERTAZZOLI C, 1979, CANCER TREAT REP, V63, P1877
[5]  
BILLINGHAM ME, 1978, CANCER TREAT REP, V62, P865
[6]  
BURHOLT DR, 1977, CANCER RES, V37, P22
[7]   EFFECTS OF ADRIAMYCIN ON MURINE DUODENAL CRYPT CELL-PROLIFERATION [J].
DETHLEFSEN, LA ;
RILEY, RM .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1979, 5 (04) :501-506
[8]  
DOROSHOW JH, 1979, CANCER TREAT REP, V63, P855
[9]   ENZYMATIC DEFENSES OF THE MOUSE HEART AGAINST REACTIVE OXYGEN METABOLITES - ALTERATIONS PRODUCED BY DOXORUBICIN [J].
DOROSHOW, JH ;
LOCKER, GY ;
MYERS, CE .
JOURNAL OF CLINICAL INVESTIGATION, 1980, 65 (01) :128-135
[10]  
DOROSHOW JH, 1979, RES COMMUN CHEM PATH, V26, P285